GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Short-Term Capital Lease Obligation

PharmaRoth Labs (PharmaRoth Labs) Short-Term Capital Lease Obligation : $0.00 Mil (As of Mar. 2011)


View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Short-Term Capital Lease Obligation?

PharmaRoth Labs's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2011 was $0.00 Mil.


PharmaRoth Labs Short-Term Capital Lease Obligation Historical Data

The historical data trend for PharmaRoth Labs's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Short-Term Capital Lease Obligation Chart

PharmaRoth Labs Annual Data
Trend Jun08 Jun09 Jun10
Short-Term Capital Lease Obligation
- - -

PharmaRoth Labs Quarterly Data
Mar07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaRoth Labs Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


PharmaRoth Labs Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaRoth Labs (PharmaRoth Labs) Business Description

Industry
Traded in Other Exchanges
N/A
Address
8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117
PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines